doi:10.3969/j.issn.1671-2587.2022.02.001

JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE ›› 2022, Vol. 24 ›› Issue (2): 137-141.DOI: 10.3969/j.issn.1671-2587.2022.02.001

Received:2021-09-29 Published:2022-04-12

[1] STORRY J R,JÖUD M,CHRISTOPHERSEN M K,et al. Homozygosity for a null allele of SMIM1 defines the Vel-negative blood group phenotype[J]. Nat Genet,2013,45(5):537-541.
[2] STORRY J R,CLAUSEN F B,CASTILHO L,et al.International society of blood transfusion working party on red cell immunogenetics and blood group terminology:report of the Dubai,Copenhagen and Toronto meetings[J]. Vox Sang,2019,114(1):95-102.
[3] DANIELS G,BALLIF B A,HELIAS V,et al.Lack of the nucleoside transporter ENT1 results in the Augustine-null blood type and ectopic mineralization[J]. Blood,2015,125(23):3651-3654.
[4] VRIGNAUD C, MIKDAR M, KOEHL B, et al.Alloantibodies directed to the SLC44A2/CTL2 transporter define two new red cell antigens and a novel human blood group system[J]. Transfusion, 2019, 59(suppl. s3): 18A.
[5] NAIR T S,KOZMA KE,HOEFLING NL,et al.Identification and characterization of choli ne transporter-like protein 2,an inner ear glycoprotein of 68 and 72 kDa that is the target of antibody-induced hearing loss[J]. J Neurosci,2004,24(7):1772-1779.
[6] KLEINMAN S, CAULFIELD T, CHAN P, et al.Toward an understanding of transfusion-related acute lung injury: statement of a consensus panel[J]. Transfusion, 2004, 44(12): 1774-1789.
[7] FLESCH B K,WESCHE J,BERTHOLD T,et al.Expression of the CTL2 transcript variants in human peripheral blood cells and human tissues[J]. Transfusion,2013,53(12):3217-3223.
[8] GREINACHER A,WESCHE J,HAMMER E,et al.Characterization of the human neutrophil alloantigen-3a[J]. Nat Med,2010,16(1):45-48.
[9] KOMMAREDDI P,NAIR T,KAKARAPARTHI B N,et al.Hair cell loss,spiral ganglion degeneration,and progressive sensorineural hearing loss in mice with targeted deletion of SLC44A2/Ctl2[J]. J Assoc Res Otolaryngol,2015,16(6):695-712.
[10] ALLEN B J,MASTRANGELO Michael A,TURE Sara K,et al.The choline transporter SLC44A2 controls platelet activation and thrombosis by regulating mitochondrial function[J]. Nat Commun,2020,11(1):3479.
[11] DANIELS G L,SIMARD H,GOLDMAN M,et al.PEL,a 'new' high-frequency red cell surface antigen[J]. Vox Sang,1996,70(1):31-33.
[12] AZOUZI S,MIKDAR M,HERMAND P,et al.Lack of the multidrug transporter MRP4/ABCC4 defines the PEL-negative blood group and impairs platelet aggregation[J]. Blood,2020,135(6):441-448.
[13] GENOMES PROJECT CONSORTIUM 1 0 0 0,AUTON A,BROOKS L D,et al. A global reference for human genetic variation[J]. Nature,2015,526(7571):68-74.
[14] SCHUETZ J D.“OMICs” reveal the molecular basis of a rare blood group[J]. Blood,2020,135(6):396-397.
[15] LOW F G,SHABIR K,BROWN J E,et al.Roles of ABCC1 and ABCC4 in proliferation and migration of breast cancer cell lines[J]. Int J Mol Sci,2020,21(20):7664.
[16] CHEEPALA S B,PITRE A,FUKUDA Y,et al.The ABCC4 membrane transporter modulates platelet aggregation[J]. Blood,2015,126(20):2307-2319.
[17] DECOUTURE B,DREANO E,BELLEVILLE-ROLLAND T,et al.Impaired platelet activation and cAMP homeostasis in MRP4-deficient mice[J]. Blood,2015,126(15):1823-1830.
[18] TEMPERILLI F,DI FRANCO M,MASSIMI I,et al.Nonsteroidal anti-inflammatory drugs in-vitro and in-vivo treatment and Multidrug Resistance Protein 4 expression in human platelets[J]. Vasc Pharmacol,2016,76:11-17.
[19] MONTGOMERY W M,NANCE S J,DONNELLY S F,et al.MAM:a “new” high-incidence antigen found on multiple cell lines[J]. Transfusion,2000,40(9):1132-1139.
[20] THORNTON N,CREW V K,TILLEY L,et al.Disrupti on of the tumour-associated EMP3 enhances erythroid proliferation and causes the MAM-negative phenotype[J]. Nat Commun,2020,11(1):3569.
[21] BEN-PORATH I,KOZAK C A,BENVENISTY N.Chromosomal mapping of Tmp (Emp1),Xmp (Emp2),and Ymp (EMP3),genes encoding membrane proteins related to Pmp22[J]. Genomics,1998,49(3):443-447.
[22] HAGEN S J.Non-canonical functions of claudin proteins:beyond the regulation of cell-cell adhesions[J]. Tissue Barriers,2017,5(2):e1327839.
[23] AHMAT AMIN M K B,SHIMIZU A,OGITA H. The pivotal roles of the epithelial membrane protein family in cancer invasiveness and metastasis[J]. Cancers,2019,11(11):1620.
[24] DANIELS G L,TALIANO V,KLEIN M T,et al.Emm. A red cell antigen of very high frequency[J]. Transfusion,1987,27(4):319-321.
[25] DUVAL R,NICOLAS G,WILLEMETZ A,et al.Inherited glycosylphosphatidylinositol defects cause the rare Emm-negative blood phenotype and developmental disorders[J]. Blood,2021,137(26):3660-3669.
[26] LANE W J,AESCHLIMANN J,VEGE S,et al.PIGG defines the Emm blood group system[J]. Sci Rep,2021,11(1):18545.
[27] KINOSHITA T.Biosynthesis and deficiencies of glycosylphosphatidylinositol[J]. Proc Jpn Acad Ser B Phys Biol Sci,2014,90(4):130-143.
[28] MAKRYTHANASIS P,KATO M,ZAKI M S,et al.Pathogenic variants in PIGG cause intellectual disability with seizures and hypotonia[J]. Am J Hum Genet,2016,98(4):615-626.
[29] WAGNER M M,VAN DUNNÉ F M,KUIPERS I,et al. Anti-Emm in a pregnant patient— case report[J]. Vox Sang,2014,106(4):385-386.
[30] OEPKES D,VAN KAMP I L,SIMON M J,et al. Clinical value of an antibody-dependent cell-mediated cytotoxicity assay in the management of Rh D alloimmunization[J]. Am J Obstet Gynecol,2001,184(5):1015-1020.
[31] FUJITA M,MAEDA Y,RA M,et al.GPI glycan remodeling by PGAP5 regulates transport of GPI-anchored proteins from the ER to the Golgi[J]. Cell,2009,139(2):352-365.
[32] PARSAMANESH N,SAFARPOUR H,ETESAM S,et al.Identification and in silico characterization of a novel point mutation within the phosphatidylinositol glycan anchor biosynthesis class G gene in an Iranian family with intellectual disability[J]. J Mol Neurosci,2019,69(4):538-545.
[33] SUGIER H, VRIGNAUD C, DUVAL R, et al.Null allele of ABCC1 encoding the multidrug resistance protein 1 defines a novel human blood group system[J]. Vox Sang, 2020, 115(suppl. s1): 40-41.
[34] COLE S P C. Targeting multidrug resistance protein 1 (MRP1,ABCC1):past,present,and future[J]. Annu Rev Pharmacol Toxicol,2014,54:95-117.
[35] COLE S P C. Multidrug resistance protein 1 (MRP1,ABCC1),a “multitasking” ATP-binding cassette (ABC) transporter[J]. J Biol Chem,2014,289(45):30880-30888.
[36] LESLIE E M.Arsenic-glutathione conjugate transport by the human multidrug resistance proteins (MRPs/ABCCs)[J]. J Inorg Biochem,2012,108:141-149.
[37] ROBEY R W,PLUCHINO K M,HALL M D,et al. Revisiting the role of ABC transporters in multidrug-resistant cancer[J]. Nat Rev Cancer,2018,18(7):452-464.
[38] FONSECA L M,ALVAREZ A B,RODRIGUES R C,et al.ABCC1 is related to the protection of the distal nephron against hyperosmolality and high sodium environment:possible implications for cancer chemotherapy[J]. PLoS One,2013,8(6):e68049.

RichHTML

PDF

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

About

Author

Journal

Access Statistics

Contact

[1]	ZHANG Ruo-yang, YANG Dong, FENG Chen-chen, et al. Identification of ABO Elution Subtypes by Genotyping Technology [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2022, 24(2): 142-146.
[2]	FENG Chen-chen, SHI Li-li, LI Hui, et al. A c.955C>G Variation Causing ABO Allelic Enhancement Phenomenon：A Case and Literature Review [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2022, 24(2): 147-150.
[3]	NIU Jia-meng, LI Xue-lian, LIU Qiu-ju, et al. Analysis of Coagulation Indexes of Hospitalized Newborns with Blood Transfusion in China [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2022, 24(2): 151-156.
[4]	QUAN Xue-li, WANG Jie, WANG Feng, et al. Blood Components Usage during Extracorporeal Membrane Oxygenation in 41 Neonates [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2022, 24(2): 197-201.
[5]	LI Zheng-ye, WANG Hao, SHI Wei, et al. The Effect of Autologous Platelet Separation and Transfusion on Blood Transfusion Volume in Aortic Dissection with Different Platelet Levels [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2022, 24(2): 207-210.
[6]	ZHANG Yong-sheng, ZHENG Wei-wei, LIU Chang-qing. Effects of Liberal Versus Restrictive Transfusion Thresholds on Survival and Neurocognitive Outcomes in Extremely Low-Birth-Weight Infants：a Systematic Review and Meta-analysis of Randomized Trials [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2022, 24(2): 211-217.
[7]	LIU Qin, XU Chun-fen, SONG Jie, et al. Clinical Observation of Different Therapeutic dose Platelets in 56 Pediatric Patients with Acute Lymphoblastic Leukemia [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2022, 24(2): 218-221.
[8]	. [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2022, 24(2): 253-257.
[9]	. [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2022, 24(2): 258-263.
[10]	. [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2022, 24(2): 264-267.
[11]	ZHANG Rong, WANG Wen-ting, GU Shun-li, et al. Discussion on Monitoring Process and Blood Transfusion Strategy of Passenger Lymphocyte Syndrome [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2021, 23(6): 681-685.
[12]	WANG Qian, YANG Li-hui, DING Tian-ling, et al. Clinical Analysis of Platelet Transfusion for Patients Undergoing Autologous Hematopoietic Stem Cell Transplantation with Different Conditioning Regimens [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2021, 23(6): 686-692.
[13]	. [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2021, 23(6): 693-695.
[14]	. [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2021, 23(6): 696-699.
[15]	FU Xiao-yan, ZHANG shuai-hang, SHAO hua, et al. Impact of Erythrocyte Storage Duration on Blood Indexes in Children with Open Heart Surgery by Cardiopulmonary Bypass [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2021, 23(6): 700-703.